Overview

Bispecific antibodies (BsAbs) are an emerging therapeutic modality designed to simultaneously engage two different antigens or epitopes, enabling functions such as redirecting immune cells to tumors, enhancing target specificity, and overcoming resistance mechanisms seen in conventional monoclonal antibodies. At ACROBiosystems, we have developed a comprehensive BsAb R&D solution, encompassing target proteins, cell lines, assay kits, antibody tools, and analytical services. This solution empowers the full workflow—from candidate screening to functional validation—accelerating your innovative drug development process.
Overview

Resources

High-Quality CD3 Proteins Empower TCE Development

High-Quality CD3 Proteins Empower TCE Development

Request PDF
Total Solutions for The Development of Bispecific Antibody

Total Solutions for The Development of Bispecific Antibody

Request PDF
TCR–CD3 Complex Unlock Superior CD3 Epitopes with Native Assembly

TCR–CD3 Complex Unlock Superior CD3 Epitopes with Native Assembly

Request PDF
Bridging ELISA Kits Streamline Your Bispecific Antibody Activity Assessment_EN-130

Bridging ELISA Kits Streamline Your Bispecific Antibody Activity Assessment_EN-130

Request PDF
High-Quality CD3 Proteins Empower TCE Development

High-Quality CD3 Proteins Empower TCE Development

Request PDF
Total Solutions for The Development of Bispecific Antibody

Total Solutions for The Development of Bispecific Antibody

Request PDF
TCR–CD3 Complex Unlock Superior CD3 Epitopes with Native Assembly

TCR–CD3 Complex Unlock Superior CD3 Epitopes with Native Assembly

Request PDF
Bridging ELISA Kits Streamline Your Bispecific Antibody Activity Assessment_EN-130

Bridging ELISA Kits Streamline Your Bispecific Antibody Activity Assessment_EN-130

Request PDF

Webinars

webinar
play
webinar
play

Frequently Asked Questions

Q

What are the main challenges in bispecific antibody development?

Bispecific antibody development is challenging because these molecules require careful design, engineering, and characterization. Key challenges include selecting the right target pair, choosing an appropriate molecular format, ensuring correct chain pairing, and maintaining structural stability. Aggregation, manufacturability, immunogenicity, and batch consistency also require close evaluation. Because bispecific antibodies act through dual-binding mechanisms, their potency and functional assays are often more complex than those used for conventional monoclonal antibodies.
Q

Why are bispecific antibodies important in next-generation therapeutics?

Bispecific antibodies are important in next-generation therapeutics because they enable treatment mechanisms beyond traditional single-target monoclonal antibodies. By engaging two targets or pathways, bispecific antibodies can improve targeting precision, enhance therapeutic activity, and help address resistance mechanisms in complex diseases. This is especially valuable in areas where single-pathway inhibition may be insufficient. Their flexible design also supports broader therapeutic applications, including oncology, immune modulation, and other complex disease settings.
Q

How do bispecific antibodies work?

Bispecific antibodies are engineered biologics designed to recognize and bind two different antigens, or two distinct epitopes on the same antigen. This dual-binding capability enables mechanisms that are difficult to achieve with conventional monoclonal antibodies. For example, T-cell engagers can bridge a tumor-associated antigen with CD3 on T cells, redirecting immune cells to attack tumor cells. Other bispecific antibodies may block two signaling pathways at the same time, improve target specificity, or require dual-antigen expression to enhance selective activity.

Explore More Topics

Cell and Gene Therapy

Cell and Gene Therapy

Antibody-Drug Conjugates

Antibody-Drug Conjugates

CMC Manufacturing & QC

CMC Manufacturing & QC

Disease Areas

Disease Areas

Vaccines

Vaccines

Research & Innovation

Research & Innovation

Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호